Geron Corporation 0IV3.L Stock
Geron Corporation Price Chart
Geron Corporation 0IV3.L Financial and Trading Overview
| Geron Corporation stock price | 3.67 USD |
| Previous Close | 3.09 USD |
| Open | 0 USD |
| Bid | 0 USD x N/A |
| Ask | 0 USD x N/A |
| Day's Range | 0 - 0 USD |
| 52 Week Range | 0 - 4.11 USD |
| Volume | 11.4K USD |
| Avg. Volume | 5.63K USD |
| Market Cap | 5.19M USD |
| Beta (5Y Monthly) | 0.895774 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.359 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
0IV3.L Valuation Measures
| Enterprise Value | 1.25B USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 10.512089 |
| Price/Book (mrq) | 4.695788 |
| Enterprise Value/Revenue | 2526.531 |
| Enterprise Value/EBITDA | -8.341 |
Trading Information
Geron Corporation Stock Price History
| Beta (5Y Monthly) | 0.895774 |
| 52-Week Change | 144.31% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 4.11 USD |
| 52 Week Low | 0 USD |
| 50-Day Moving Average | 2.78 USD |
| 200-Day Moving Average | 2.55 USD |
0IV3.L Share Statistics
| Avg. Volume (3 month) | 5.63K USD |
| Avg. Daily Volume (10-Days) | 5.7K USD |
| Shares Outstanding | 186.35M |
| Float | 449.67M |
| Short Ratio | N/A |
| % Held by Insiders | 0.12% |
| % Held by Institutions | 44.85% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -30357.69% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -30.075% |
| Return on Equity (ttm) | -70.79% |
Income Statement
| Revenue (ttm) | 494K USD |
| Revenue Per Share (ttm) | 0.001 USD |
| Quarterly Revenue Growth (yoy) | -82.89% |
| Gross Profit (ttm) | -93668000 USD |
| EBITDA | -149636992 USD |
| Net Income Avi to Common (ttm) | -149924992 USD |
| Diluted EPS (ttm) | -0.359 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 380.74M USD |
| Total Cash Per Share (mrq) | 0.75 USD |
| Total Debt (mrq) | 55.84M USD |
| Total Debt/Equity (mrq) | 17.13 USD |
| Current Ratio (mrq) | 8.814 |
| Book Value Per Share (mrq) | 0.641 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -139770000 USD |
| Levered Free Cash Flow (ttm) | -87059504 USD |
Profile of Geron Corporation
| Country | United Kingdom |
| State | CA |
| City | Foster City |
| Address | 919 East Hillsdale Boulevard |
| ZIP | 94404 |
| Phone | 650 473 7700 |
| Website | https://www.geron.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | 107 |
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in myeloid hematologic malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.
Q&A For Geron Corporation Stock
What is a current 0IV3.L stock price?
Geron Corporation 0IV3.L stock price today per share is 3.67 USD.
How to purchase Geron Corporation stock?
You can buy 0IV3.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Geron Corporation?
The stock symbol or ticker of Geron Corporation is 0IV3.L.
How many shares does Geron Corporation have in circulation?
The max supply of Geron Corporation shares is 1.73M.
What is Geron Corporation Price to Earnings Ratio (PE Ratio)?
Geron Corporation PE Ratio is now.
What was Geron Corporation earnings per share over the trailing 12 months (TTM)?
Geron Corporation EPS is -0.359 USD over the trailing 12 months.